Home › NDC Lookup › RxCUI directory › RxCUI 2591793

Daptomycin 500 MG Injection [Dapzura] — RxCUI 2591793

RxNorm drug concept · Semantic branded drug
RxCUI 2591793 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 0 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2591793
Official nameDaptomycin 500 MG Injection [Dapzura]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDapzura 500 MG Injection
FDA products mapped1
Package NDCs mapped0
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Daptomycin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Daptomycin only comes as an intravenous (IV) medication — there is no pill form. It needs to go directly into your bloodstream to reach the serious infection it's treating, like a...
  • Why am I getting daptomycin by IV instead of a pill?
  • It depends on what's being treated. For complicated skin infections, treatment usually lasts 7 to 14 days. For a bloodstream infection, it can be 2 to 6 weeks. Your doctor will dec...
  • How long will I need to be on this antibiotic?
📖 Read our full Daptomycin Injection guide →

🕸️ Concept Web — How Daptomycin 500 MG Injection [Dapzura] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Daptomycin 500 MG Injection [Dapzura] RxCUI 2591793

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Daptomycin 22299
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dapzura 2591789
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Daptomycin Injection 1731096
    • Daptomycin Injectable Product 1152143
    • Daptomycin Injection [Dapzura] 2591792
    • Dapzura Injectable Product 2591791
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Daptomycin 500 MG Injection SCD · 403920
  • Daptomycin 500 MG SCDC · 1731095
  • Daptomycin Injection SCDF · 1731096
  • Daptomycin Injectable Product SCDG · 1152143

Brand-Name Concepts

  • Daptomycin 500 MG [Dapzura] SBDC · 2591790
  • Daptomycin Injection [Dapzura] SBDF · 2591792
  • Dapzura Injectable Product SBDG · 2591791
  • Dapzura BN · 2591789

📦 FDA Products & Package NDCs

1 product · 0 package NDCs
No package NDCs are mapped to this concept in the current snapshot. Missing rows here mean the openFDA export did not annotate a listing with this RxCUI — never that no product exists.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.